Navigation Links
Generex Common Stock to be Quoted on the OTCQB Under the Symbol 'GNBT' Beginning Thursday, October 21, 2010
Date:10/19/2010

he Company's Board of Directors as a means of maintaining the Company's NASDAQ listing did not achieve the necessary vote in time for the meeting.

Of the 269,360,643 shares outstanding as of the August 12 record date, 191,872,323 shares (71.24%) were voted.  The 127,819,048 shares voted in favor of the proposal represented 66.61% of votes cast and 47.45% of the outstanding shares.  Approval of the proposal required a majority of the outstanding shares to vote in favor; accordingly, the vote fell 2.56% short.

During the week following the Company's October 11th announcement of its pending acquisition of a 51% equity interest in Global Medical Direct, LLC, interest in the reverse stock split proposal increased dramatically.  During that period, the number of shares voted in favor of the proposal increased by 42,312,013 (an increase of nearly 50%) and the number of shares voted against the proposal decreased by 29,497,077 (a decrease of almost 32%) and the number of shares voted overall increased by 11,749,664 (a 13% increase).

In light of the increased stockholder support for the reverse stock split proposal as evidenced by the voting pattern over the past week, the Company will appeal the Panel's delisting determination to the NASDAQ Listing and Hearing Review Council.  The Listing Council is a standing independent advisory committee appointed by NASDAQ's Board of Directors that, among other things, hears appeals of Panel decisions to delist.  The suspension of the Company's common stock from trading on NASDAQ will remain in place throughout the appeal process, although the stock will be quoted on the OTCQB during that time.

About Pink OTC Markets Inc.

Pink OTC Markets Inc. is a financial information and technology services company that operates an inter-dealer electronic quotation and trading system in the Over-The-Counter (or OTC) securities market.  It is not registered with the Securities and
'/>"/>

SOURCE Generex Biotechnology Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Generex Provides Additional Reverse Stock Split Information for the Consideration of Stockholders
2. Generex Scientific Advisor Weighs in on Reverse Stock Split Proposal
3. Generex Plans Rights Offering to Stockholders Following Reverse Stock Split
4. Generex Biotechnology Appoints Mark Fletcher as Interim President and CEO, and John P. Barratt as Chairman of the Board
5. Generex Announces That Adjournment will be Sole Matter Considered at Special Meeting of Stockholders on September 17, 2010
6. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Generex Biotechnology Corporation
7. deCODE Discovers Major Genetic Risk Factor for the Most Common Form of Glaucoma
8. Delcath Systems Announces the Sale of 5,185,000 Shares of Common Stock
9. PDL BioPharma Announces Retirement of $61.6 Million of 2.75% Convertible Notes due August 2023 for Common Stock
10. Advanced Life Sciences CEO Acquires $2 Million of Common Stock Through Debt for Equity Exchange
11. DATATRAK Completes Sale of 357,857 Common Shares to Directors and Management
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/8nqqdw/global_breast ) has announced ... Monoclonal Antibodies Market Outlook 2020" report to ... dominate the breast cancer monoclonal antibody segment because ... has been able to dominate this segment for ... cells become recalcitrant and relapsed condition could not ...
(Date:5/27/2015)... May 27, 2015  Tikcro Technologies Ltd. (OTCQB: TIKRF) ... 31, 2015. Aviv Boim , ... pre-clinical work to generate functional specific antibodies, targeting identified ... we are encouraged by the development progress. We are ... antibodies which modulate immune checkpoints gain clinical acceptance for ...
(Date:5/27/2015)... Md. , May 27, 2015  Northwest Biotherapeutics, ... company developing DCVax® personalized immune therapies for cancer, announced ... Technical Officer of the Company, will be making an ... Meeting in Chicago on Saturday, ... at the Industry Expert Theater in McCormick Place. ...
(Date:5/27/2015)... May 27, 2015  RXi Pharmaceuticals Corporation (NASDAQ: ... discovering and developing innovative therapies primarily in the ... on the status of the Company,s Series A ... Logo - http://photos.prnewswire.com/prnh/20130917/NE80755LOGO ... 21 shares of Series A Preferred Stock and ...
Breaking Biology Technology:Global Breast Cancer Monoclonal Antibodies Market Outlook 2020 2Global Breast Cancer Monoclonal Antibodies Market Outlook 2020 3Tikcro Technologies Reports First Quarter 2015 Results 2Tikcro Technologies Reports First Quarter 2015 Results 3NW Bio To Present Overview Of DCVax-Direct Phase I Trial In Chicago This Weekend 2NW Bio To Present Overview Of DCVax-Direct Phase I Trial In Chicago This Weekend 3RXi Pharmaceuticals Provides an Update on Series A and Series A-1 Preferred Stock 2RXi Pharmaceuticals Provides an Update on Series A and Series A-1 Preferred Stock 3
... of financial technology solutions and subsidiary of Marshall and ... Virginia and Pennsylvania. , ,On Monday the company announced they ... origination solutions headquartered in Wayne, Pa. GHR was acquired for ... the third quarter of 2005. , ,Metavante said in their ...
... 18,000 people who recently attended BIO 2005 in Philadelphia made me ... its also becoming mainstream in the world economy. , ,It also ... 1960s. Though most adults at first wouldnt accept it, the launch ... a statement that rock was here to stay. So is biotech! ...
... be misleading to suggest that scientists at UW-Madison or anywhere ... fact, no scientist in the state has even announced plans ... to suggest the process for cloning a human embryo for ... from the process used in therapeutic cloning. The first step ...
Cached Biology Technology:Biotech phenomenon becoming mainstream in world economy 2Biotech phenomenon becoming mainstream in world economy 3Biotech phenomenon becoming mainstream in world economy 4Biotech phenomenon becoming mainstream in world economy 5The Attack of the Clones: No, its not a summer movie 2The Attack of the Clones: No, its not a summer movie 3
(Date:5/22/2015)...  NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the ... its promotional pricing and making the Wocket generally available for ... , Head of Marketing said, "We,ve extended the opportunity to ... of May. To get your wocket at this special price, ... store on June 1, you,ll receive a unique code that ...
(Date:5/20/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... LLC, a company engaged in biometric identification is an ... portion of the recently awarded TIES (Technical Information Engineering ... Army. 3D-ID LLC has a suite of ... and security agencies. Gino Pereira , ...
(Date:5/14/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/5whpxg/fingerprint ) has ... in Smart Mobile Devices " report to their ... a watershed year for fingerprint sensors in smartphones and ... gave fingerprint sensors a raison d,etre in the mobile ... a must-have feature in flagship smartphones. The ...
Breaking Biology News(10 mins):NXT-ID, Inc Announces Retail Price For Wocket Smart Wallet And Extends Discounted Promotional Price Till End Of May 2NXT-ID, Inc Announces Retail Price For Wocket Smart Wallet And Extends Discounted Promotional Price Till End Of May 3NXT-ID, Inc Announces Participation as Member of Team Battelle for TIES Contract Award 2NXT-ID, Inc Announces Participation as Member of Team Battelle for TIES Contract Award 3Global Smart Mobile Devices Fingerprint Sensors Market 2015-2019: Key Vendors are Authentec, Validity Sensors, Fingerprint Cards, Next Biometrics Group. IDEX, and Qualcomm 2
... by a University of Tennessee, Knoxville professor has found ... human colonization. Research by Alison Boyer, a ... an international team studied the extinction rates of nonperching ... 3,500 years ago. Some of the birds studied included ...
... is best known for promoting erections, it may also serve as ... healthy "brown fat" relative to unhealthy "white fat" than it would ... online in The FASEB Journal , this is ... well known as a messenger molecule used by the body to ...
... School of Medicine have discovered a new biological pathway ... identified agents that can block it, leading to increased ... pneumonia. They reported their findings today in Nature ... an inflammatory response from the body that is more ...
Cached Biology News:University of Tennessee professor links massive prehistoric bird extinction to human colonization 2Drug for erectile disorder show promise in the treatment of obesity 2Pitt team finds immunity protein that ramps up inflammation, and agents that can block it 2
... The Staccato Application Series are ... systems designed to provide fast and ... Utilizing proven and robust "automation-friendly" building ... solutions that cost less than conventional ...
... Guava has made microcapillary flow cytometry accessible ... experts alike will appreciate the latest addition ... Pluseasy to use, surprising affordable, and very ... system includes such features as absolute cell ...
... Rotator, variable speed, timer, SB3, Fully adjustable ... of tube holders to hold a number ... SB3 is ideal for aerating cultures, keeping ... mixing applications., The rotator can be used ...
... Accuri's C6 Flow Cytometer System is a full ... system including: the C6 Flow Cytometer, CFlow Software, ... C6 Flow Cytometer System provides all the capabilities ... fraction of the price. The C6 Flow Cytometer ...
Biology Products: